推荐产品
等级
technical grade
方案
85%
表单
liquid
折射率
n20/D 1.4408 (lit.)
沸点
95-96 °C/0.4 mmHg (lit.)
密度
0.845 g/mL at 25 °C (lit.)
SMILES字符串
CCCCCCCCCCCCC1CO1
InChI
1S/C14H28O/c1-2-3-4-5-6-7-8-9-10-11-12-14-13-15-14/h14H,2-13H2,1H3
InChI key
IOHJQSFEAYDZGF-UHFFFAOYSA-N
警示用语：
Warning
危险声明
危险分类
Aquatic Acute 1 - Aquatic Chronic 1 - Skin Irrit. 2
储存分类代码
10 - Combustible liquids
WGK
WGK 1
闪点(°F)
221.0 °F - closed cup
闪点(°C)
105 °C - closed cup
个人防护装备
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Ping Song et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 27(8), 1424-1435 (2019-06-04)
Interleukin-1 beta (IL-1β) plays a central role in the induction of rheumatoid arthritis (RA). In the present study, we demonstrated that lipidoid-polymer hybrid nanoparticle (FS14-NP) can efficiently deliver siRNA against IL-1β (siIL-1β) to macrophages and effectively suppress the pathogenesis of
Eva Ramsay et al.
Pharmaceutics, 12(7) (2020-07-28)
Inflammation is involved in the pathogenesis of several age-related ocular diseases, such as macular degeneration (AMD), diabetic retinopathy, and glaucoma. The delivery of anti-inflammatory siRNA to the retinal pigment epithelium (RPE) may become a promising therapeutic option for the treatment
Shantipriya Khadka et al.
Electrophoresis, 37(23-24), 3160-3171 (2016-09-10)
A novel precursor monolithic capillary column referred to as "hydroxy monolith" or OHM was prepared by the in situ copolymerization of hydroxyethylmethacrylate (HEMA) with pentaerythritol triacrylate (PETA) yielding the neutral poly(HEMA-co-PETA) monolith. The neutral precursor OHM capillary thus obtained was
Wei Tao et al.
Science translational medicine, 12(553) (2020-07-29)
Atherosclerotic lesional macrophages express molecules that promote plaque progression, but lack of mechanisms to therapeutically target these molecules represents a major gap in translational cardiovascular research. Here, we tested the efficacy of a small interfering RNA (siRNA) nanoparticle (NP) platform
Rachel S Riley et al.
Science advances, 7(3) (2021-02-02)
Clinical advances enable the prenatal diagnosis of genetic diseases that are candidates for gene and enzyme therapies such as messenger RNA (mRNA)-mediated protein replacement. Prenatal mRNA therapies can treat disease before the onset of irreversible pathology with high therapeutic efficacy
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门